LOS ANGELES, CA

The company is pleased to announce that it has entered into a Non Disclosure Agreement (NDA) with one of the worlds largest and most reputable sugar companies with an annual multi-billion dollar turnover.

The purpose of the agreement is to have their scientists evaluate the product recently approved by the FDA (Food and Drug Administration) with the object of commercialization worldwide. Two patents cover the product. Besides being an ingredient that can replace sugar in thousands of products, it is the perfect product for the diabetic and obesity market.

This amazing new product is produced by creating an enzymatic degradation of natural crops which is then processed and purified. The end result is an all-natural sweetener that looks exactly like honey, tastes like honey, and has the same consistency as honey. It is also available in powder form.

Unlike other sweeteners, including sugar, this product provides no glycemic spike in diabetics when taken. The incredible science behind the product does not allow any enzyme in the human body to digest the sweetener. For Diabetics this product is being touted as the greatest invention since Insulin.

Diabetes effects an estimated billion people around the world, almost one sixth of the worlds population! Diabetes is also closely associated with obesity.

For further info contact: superv0007@hotmail.com

Safe Harbor Statement

All statements other than statements of historical fact included in this press release are "forward looking statements." The forward-looking statements, including statements about the Company's future, revenues and earnings, and all other forward looking statements (i.e. future operational results and sales) are subject to assumptions and beliefs based on current information known to the Company and are factors that are subject to uncertainties, risks and other influences which are outside the Company's control, and which may yield results differing materially and substantially from those anticipated. Any reference to a private placement is not an offering or a solicitation of any kind and is to be considered a notice only. All information is subject to change.

Contact: SuperVision Entertainment Inc. Email Contact

BioNeutra (CE) (USOTC:BIMO)
Historical Stock Chart
From Feb 2025 to Mar 2025 Click Here for more BioNeutra (CE) Charts.
BioNeutra (CE) (USOTC:BIMO)
Historical Stock Chart
From Mar 2024 to Mar 2025 Click Here for more BioNeutra (CE) Charts.